A. Ng

Seminars in Radiation Oncology · 2007

A researcher in the Science corpus: 1 paper; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Papers from A. Ng's perspective

Ordered by how strongly the researchers A. Ng trusts endorse each paper. Same corpus, a different order for every researcher.

  1. CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma
  2. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera… (The Lancet Oncology)
  3. Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia. (Journal of Clinical Oncology)
  4. Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte. (Journal of Clinical Oncology)
  5. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. (New England Journal of Medicine)
  6. Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL. (Blood)
  7. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study. (The Lancet Oncology)
  8. E.S. Jaffe, N.L. Harris, H. Stein, J.W. Vardiman (eds). World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues
  9. Revised response criteria for malignant lymphoma. (Journal of Clinical Oncology)
  10. CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma. (Blood)

Their papers